Clinical trial
Pimozide Augmentation of Clozapine in Schizophrenia
NCT00158223 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pimozide Augmentation of Clozapine in Schizophrenia
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2004
- Completion date
- February 28, 2009
- Enrollment
- 76 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.